Literature DB >> 17501975

Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints.

L Jakobsen1, D Sandvang, V F Jensen, A M Seyfarth, N Frimodt-Møller, A M Hammerum.   

Abstract

In total, 120 Escherichia coli isolates positive for one of the gentamicin resistance (GEN(R)) genes aac(3)-II, aac(3)-IV or ant(2'')-I were tested for gentamicin susceptibility by the agar dilution method. Isolates positive for aac(3)-IV or ant(2'')-I had an MIC distribution of 8-64 mg/L, whereas isolates positive for aac(3)-II had MICs of 32 to >512 mg/L, suggesting a relationship between the distribution of MICs and the specific GEN(R) mechanism. The MIC distribution, regardless of the GEN(R) mechanism, was 8 - >512 mg/L, which supports the clinical breakpoint of MIC >4 mg/L suggested by EUCAST and questions the breakpoint recommended by the CLSI (> or =16 mg/L).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17501975     DOI: 10.1111/j.1469-0691.2007.01751.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  7 in total

1.  Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.

Authors:  Reem Almaghrabi; Cornelius J Clancy; Yohei Doi; Binghua Hao; Liang Chen; Ryan K Shields; Ellen G Press; Nicole M Iovine; Bethany M Townsend; Marilyn M Wagener; Barry Kreiswirth; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

2.  Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species.

Authors:  Ghady Haidar; Ammar Alkroud; Shaoji Cheng; Travis M Churilla; Bryce M Churilla; Ryan K Shields; Yohei Doi; Cornelius J Clancy; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

3.  Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis.

Authors:  H Malekinejad; A Nikibakhsh; S Gholizadeh-Soltani; A Farshid
Journal:  Indian J Nephrol       Date:  2012-01

4.  Frequency distribution of genes encoding aminoglycoside modifying enzymes in uropathogenic E. coli isolated from Iranian hospital.

Authors:  Neda Soleimani; Mahdi Aganj; Liaqat Ali; Leili Shokoohizadeh; Türkân Sakinc
Journal:  BMC Res Notes       Date:  2014-11-25

5.  Antimicrobial Resistance Caused by KPC-2 Encoded by Promiscuous Plasmids of the Klebsiella pneumoniae ST307 Strain.

Authors:  Miyoung Lee; Tae-Jin Choi
Journal:  Ann Lab Med       Date:  2020-08-25       Impact factor: 3.464

6.  In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.

Authors:  Mario Juhas; Emma Widlake; Jeanette Teo; Douglas L Huseby; Jonathan M Tyrrell; Yury S Polikanov; Onur Ercan; Anna Petersson; Sha Cao; Ali F Aboklaish; Anna Rominski; David Crich; Erik C Böttger; Timothy R Walsh; Diarmaid Hughes; Sven N Hobbie
Journal:  J Antimicrob Chemother       Date:  2019-04-01       Impact factor: 5.790

7.  Proton motive force underpins respiration-mediated potentiation of aminoglycoside lethality in pathogenic Escherichia coli.

Authors:  Calum M Webster; Ayrianna M Woody; Safura Fusseini; Louis G Holmes; Gary K Robinson; Mark Shepherd
Journal:  Arch Microbiol       Date:  2022-01-06       Impact factor: 2.552

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.